C
Carl Shanholtz
Researcher at University of Maryland, Baltimore
Publications - 94
Citations - 5651
Carl Shanholtz is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Lung injury & Intensive care. The author has an hindex of 35, co-authored 85 publications receiving 4838 citations. Previous affiliations of Carl Shanholtz include University of Maryland Marlene and Stewart Greenebaum Cancer Center & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients.
Roy G. Brower,Carl Shanholtz,Carl Shanholtz,Henry E. Fessler,David M. Shade,Peter White,Charles M. Wiener,John G. Teeter,John G. Teeter,Jeffrey M. Dodd-o,Yaniv Almog,Steven Piantadosi +11 more
TL;DR: The reduced tidal volume strategy used in this study was safe and effective and failure to observe beneficial effects of small tidal volume ventilation treatment in important clinical outcome variables may have occurred because a) the sample size was too small to discern small treatment effects; b) the differences in tidal volumes and plateau pressures were modest; or c) reduced tidalVolume ventilation is not beneficial.
Journal ArticleDOI
Physical complications in acute lung injury survivors: a two-year longitudinal prospective study.
Eddy Fan,Eddy Fan,David W. Dowdy,Elizabeth Colantuoni,Pedro A. Mendez-Tellez,Jonathan E. Sevransky,Carl Shanholtz,Cheryl Dennison Himmelfarb,Sanjay V. Desai,Nancy Ciesla,Margaret S. Herridge,Peter J. Pronovost,Dale M. Needham +12 more
TL;DR: Muscle weakness is common after acute lung injury, usually recovering within 12 months, and this weakness is associated with substantial impairments in physical function and health-related quality of life that continue beyond 24 months.
Journal ArticleDOI
Rosuvastatin for Sepsis-Associated Acute Respiratory Distress Syndrome
Jonathon D. Truwit,Gordon R. Bernard,Jay S. Steingrub,Michael A. Matthay,Kathleen D. Liu,Timothy E Albertson,Roy G. Brower,Carl Shanholtz,Peter Rock,Ivor S. Douglas,Bennett P. deBoisblanc,Catherine L. Hough,R. Duncan Hite,B. Taylor Thompson +13 more
TL;DR: Rosuvastatin therapy did not improve clinical outcomes in patients with sepsis-associated ARDS and may have contributed to hepatic and renal organ dysfunction, and was not associated with an increased incidence of serum creatine kinase levels that were more than 10 times the upper limit of the normal range.
Journal ArticleDOI
Lung protective mechanical ventilation and two year survival in patients with acute lung injury: prospective cohort study
Dale M. Needham,Elizabeth Colantuoni,Pedro A. Mendez-Tellez,Victor D. Dinglas,Jonathan E. Sevransky,Cheryl Dennison Himmelfarb,Sanjay V. Desai,Carl Shanholtz,Roy G. Brower,Peter J. Pronovost +9 more
TL;DR: Lung protective mechanical ventilation was associated with a substantial long term survival benefit for patients with acute lung injury and greater use of lung protective ventilation in routine clinical practice could reduce long term mortality in patients with chronic lung injury.
Journal ArticleDOI
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis
Mark M. Wurfel,Anthony C. Gordon,Tarah D. Holden,Frank Radella,Jeanna Strout,Osamu Kajikawa,John T. Ruzinski,Gail Rona,R. Anthony Black,Seth Stratton,Gail P. Jarvik,Adeline M. Hajjar,Deborah A. Nickerson,Mark J. Rieder,Jonathan E. Sevransky,James P. Maloney,Marc Moss,Greg S. Martin,Carl Shanholtz,Joe G.N. Garcia,Li Gao,Roy G. Brower,Kathleen C. Barnes,Keith R. Walley,James A. Russell,Thomas R. Martin +25 more
TL;DR: Hypermorphic genetic variation in TLR1 is associated with increased susceptibility to organ dysfunction, death, and gram-positive infection in sepsis.